A Study of Emactuzumab and RO7009789 Administered in Combination in Participants With Advanced Solid Tumors
Clinical trial NCT02760797 · COMPLETED
Trial details
- NCT number
- NCT02760797
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-09
- Primary completion
- 2018-04-06
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.